Series B - Molecular Assemblies

Series B - Molecular Assemblies

Investment Firm

Overview

Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.

Announced Date

Mar 15, 2022

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorCasdin Capital
Participant InvestorAgilent Technologies
Participant InvestorCodexis
Participant InvestorLYFE Capital
Participant InvestoriSelect Fund

Round Details and Background

Molecular Assemblies raised $25800000 on 2022-03-15 in Series B

Molecular Assemblies is developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 04, 2021
Series B - Molecular Assemblies
1-10.0M
Mar 15, 2022
Series B - Molecular Assemblies
6-25.8M
Nov 13, 2013
Grant - Molecular Assemblies
1-150.0K
Dec 12, 2016
Seed Round - Molecular Assemblies
7-2.3M

Recent Activity

There is no recent news or activity for this profile.